Woman Alleges Permanent Alopecia after Using Taxotere Chemotherapy Drug
Sanofi-Aventis is facing another lawsuit over its chemotherapy drug, Taxotere. A woman alleges that the company failed to warn about the risk of permanent alopecia, or hair loss, after taking Taxotere. She alleges that the company misled her and her oncologist about the risks of Taxotere and claims that she would have chosen a … [Read more...]
Lawsuits Filed when Permanent Chemotherapy Hair Loss is Linked to Taxotere
Breast cancer patients are usually familiar with the likely side effect of chemotherapy of hair loss. Most, however, expect that hair grows back once the chemotherapy is over. However, an increasing number of breast cancer patients are finding that this is not always the case after they have taken certain drugs. Sanofi Aventis, … [Read more...]
New Lawsuit Filed over Taxotere Alleges Permanent Hair Loss
Sanofi-Aventis is facing a new lawsuit filed over Taxotere, a chemotherapy drug used to treat breast cancer and other forms of cancer. The suit, filed on behalf of a Mississippi woman, alleges that the drug resulted in alopecia, or permanent hair loss. The suit focuses on the alleged lack of warning. The plaintiff started taking … [Read more...]
Sanofi Faces Another Lawsuit over Taxotere
Sanofi-Aventis faces another lawsuit alleging that its chemotherapy drug Taxotere led to permanent hair loss, or alopecia. The suit accuses the drug maker of failing to adequately warn about the risk of irreversible hair loss. The plaintiff is a California woman who was diagnosed with Stage II breast cancer in 2010. She underwent six … [Read more...]
Permanent Hair Loss Linked To Taxotere Breast Cancer Treatment
Hair Loss Linked To Taxotere. A number of women undergoing chemotherapy for breast cancer have recently come forward naming Taxotere (docetaxel) as a possible cause for their apparent permanent hair loss. Many have filed lawsuits against Taxotere’s manufacturer, Sanofi-Aventis. Patients are attracted to Taxotere as it is received … [Read more...]
Taxotere and the Risk of Alopecia
The U.S. Food and Drug Administration (FDA) approved Taxotere as a chemotherapy drug in 1996. Taxotere is manufactured by Sanofi-Aventis and is commonly used to treat breast cancer, as well as other cancers. Some patients taking Taxotere have reported experiencing permanent hair loss, or alopecia. In December 2015, the FDA warned … [Read more...]
Lawsuits Allege Patients were Never Warned of Permanent Baldness with Taxotere
Lawsuits are being filed over Taxotere, a chemotherapy drug manufactured by Sanofi-Aventis. Plaintiffs allege that they were never warned about the risk of permanent baldness when taking the drug, claiming they would have considered a different option if they were fully informed. Taxotere was approved by the U.S. Food and Drug … [Read more...]
